Severity of measles among patients with incidental postexposure vaccination

Japanese Journal of Infectious Diseases

Volumn 61, Issue 4, 2008, Pages 304-306

  Sakuta, Hidenari ^a   Sawada, Shojiro ^a   Kuroki, Yasutomi ^b  

^a SDF Sendai Hospital   (Japan)

^b Department of Pediatrics   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY; LACTATE DEHYDROGENASE; MEASLES ANTIBODY; MEASLES VACCINE;

ADULT; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; BODY TEMPERATURE; CLINICAL ARTICLE; CONJUNCTIVITIS; CONTROLLED STUDY; COUGHING; DIARRHEA; DISEASE SEVERITY; DRUG EXPOSURE; EPIDEMIC; FEMALE; FEVER; HEADACHE; HOSPITAL ADMISSION; HUMAN; INFECTION CONTROL; JAPAN; MALE; MEASLES; RASH; RHINORRHEA; SORE THROAT; SYMPTOM; VACCINATION;

ADOLESCENT; ADULT; CHEMOPREVENTION; DISEASE OUTBREAKS; HUMANS; JAPAN; MALE; MEASLES; MEASLES VACCINE; MEASLES VIRUS; MILITARY PERSONNEL; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VACCINATION;

EID: 48749096231     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Watson, G.I. (1963): Protection after exposure to measles by attenuated vaccine without gamma-globulin. Br. Med. J., 1, 860-861.
2. Ruuskanen, O., Salmi, T.T. and Halonen, P. (1978): Measles vaccination after exposure to natural measles. J. Pediatr., 93, 43-46.
3. Erdman, D.D., Heath, J.L., Watson, J.C., et al. (1993): Immunoglobulin M antibody response to measles virus following primary and secondary vaccination and natural virus infection. J. Med. Virol., 41, 44-48.
4. Henderson, D.A., Inglesby, T.V., Bartlett, J.G., et al. (1999): Smallpox as a biological weapon: medical and public health management. JAMA, 281, 2127-2137.
5. Jaye, A., Magnusen, A.F., Sadiq, A.D., et al. (1998): Ex vivo analysis of cytotoxic T lymphocytes to measles antigens during infection and after vaccination in Gambian children. J. Clin. Invest., 102, 1969-1977.
6. + lymphocytes in control and clearance of measles virus infection of rhesus monkeys. J. Virol., 77, 4396-4400.
7. Aaby, P., Bukh, J., Lisse, I.M., et al. (1984): Overcrowding and intensive exposure as determinants of measles mortality. Am. J. Epidemiol., 120, 49-63.
8. The Measles Vaccines Committee (1968): Vaccination against measles: clinical trial of measles vaccine given alone and live vaccine preceded by killed vaccine. Br. Med. J., 2, 449-452.
9. Mouallem, M., Friedman, E., Pauzner, R., et al. (1987): Measles epidemic in young adults. Clinical manifestations and laboratory analysis in 40 patients. Arch. Intern. Med., 147, 1111-1113.
10. Edmonson, M.B., Addiss, D.G., McPherson, J.T., et al. (1990): Mild measles and secondary vaccine failure during a sustained outbreak in a highly vaccinated population. JAMA, 263, 2467-2471.
11. Smith, F.R., Curran, A.S., Raciti, K.A., et al. (1982): Reported measles in persons immunologically primed by prior vaccination. J. Pediatr., 101, 391-393.
12. Aaby, P., Bukh, J., Leerhoy, J., et al. (1986): Vaccinated children get milder measles infection: a community study from Guinea-Bissau. J. Infect. Dis., 154, 858-863.
13. Linnemann, C.C., Jr., Rotte, T.C., Schiff, G.M., et al. (1972): A seroepidemiologic study of a measles epidemic in a highly immunized population. Am. J. Epidemiol., 95, 238-246.
14. Narita, M., Yamada, S., Matsuzono, Y., et al. (1996): Immunoglobulin G avidity testing in serum and cerebrospinal fluid for analysis of measles virus infection. Clin. Diagn. Lab. Immunol., 3, 211-215.